Venous leg ulceration pathophysiology and evidence based treatment

Yung-wei Chi, Joseph D. Raffetto

Research output: Contribution to journalArticlepeer-review

33 Scopus citations


Venous leg ulceration (VLU) is one of the most predominate medical disorders worldwide and in the western hemisphere it affects around 1.5% of the general population and up to 5% of the elderly population. Unfortunately, this trend will only increase given the growth of an aging population worldwide. Understanding its pathophysiology that begins with venous hemodynamic abnormalities and leads to inflammatory alterations with microcirculatory changes is critical to delivering effective curative therapy. As such, the main component to treatment is reversing the underlying venous hypertension and pro-inflammatory milieu using compression treatment along with various adjuvant therapies. Given its impact, a comprehensive multi-pronged approach to care, treatment and prevention is required to reverse the increasing trend that is observed worldwide.

Original languageEnglish (US)
Pages (from-to)168-181
Number of pages14
JournalVascular Medicine (United Kingdom)
Issue number2
StatePublished - Apr 4 2015


  • chronic venous disorder
  • compression therapy
  • endovenous therapy
  • inflammation
  • venous disease classification
  • venous leg ulceration

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Venous leg ulceration pathophysiology and evidence based treatment'. Together they form a unique fingerprint.

Cite this